MedPath

Investigating the SMA's Role in Speech and Reading Fluency in PWS with RTMS

Not Applicable
Conditions
Stuttering, Adult
Registration Number
NCT06809387
Lead Sponsor
Medipol University
Brief Summary

The goal of this clinical trial is to study how a part of the brain called the supplementary motor area (SMA) is connected to speech and reading fluency in adults who stutter. Researchers will use a method called repetitive transcranial magnetic stimulation (rTMS) to learn more about this relationship. The main question it aims to answer is:

-Will participants' speech and reading fluency improve when we stimulate the SMA with rTMS?

Participants will take part in both placebo rTMS and real rTMS sessions.

Participants will:

* Come to the research center for 2 days, with at least a one-week break between visits

* Read 4 passages and speak on 4 topics

* Be video recorded while doing these tasks

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • To be over 18 years of age
  • Presence of developmental stuttering
  • Being right hand dominant
Exclusion Criteria
  • Being under 18 years of age
  • The presence of a diagnosed brain lesion
  • Presence of intracranial metal implantation
  • Presence of a speech and language problem other than stuttering
  • The presence of a diagnosed neurological disorder
  • The presence of a diagnosed psychiatric disorder
  • Use of drugs and substances that may affect the central nervous system
  • History of epilepsy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Severity of stuttering in speech and reading Day 1 (pre-treatment)Immediately before the treatment (Day 1)

Stuttering severity will be calculated on video recordings taken during speaking and reading tasks. Stuttering Severity Instrument - 4th Edition (SSI-4) scale will be used for this.

Severity of stuttering in speech and reading Day 1 (post-treatment)Immediately after the treatment (Day 1)

Stuttering severity will be calculated on video recordings taken during speaking and reading tasks. Stuttering Severity Instrument - 4th Edition (SSI-4) scale will be used for this.

Severity of stuttering in speech and reading Day 2 (pre-treatment)Immediately before the treatment (Day 2)

Stuttering severity will be calculated on video recordings taken during speaking and reading tasks. Stuttering Severity Instrument - 4th Edition (SSI-4) scale will be used for this.

Severity of stuttering in speech and reading Day 2 (post-treatment)Immediately after the treatment (Day 2)

Stuttering severity will be calculated on video recordings taken during speaking and reading tasks. Stuttering Severity Instrument - 4th Edition (SSI-4) scale will be used for this.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

İstanbul Medipol Üniversitesi Dil, Konuşma ve Yutma Terapisi ve Yenilikçi Teknolojiler Merkezi (MEDKOM)

🇹🇷

İstanbul, Turkey

İstanbul Medipol Üniversitesi Dil, Konuşma ve Yutma Terapisi ve Yenilikçi Teknolojiler Merkezi (MEDKOM)
🇹🇷İstanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.